Crepis Base (Extract)

본문 바로가기


Home > Product > Crepis Base (Extract)
Product
Crepis Base (Extract)
Posting date : Mar 19, 2015
Membership
Free Member Scince Mar 16, 2015
FOB Price
negotiable
Min. Order Quantity
10g
Supply Abillity
more than 200 kg per month
Port
as require
Payment Terms
T/T,West Union,Money Gram
Package
as requirment
Keyword :
Category
Contact
Gina Yan
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
nanjian
HS-CODE
-
Package & Delivery Lead Time
Package
as requirment
Detailed Description

Product Description

Crepis base (Extract) Packing: 1kg/foil bags Assay: ≥ 99.5 Appearance: White crystalline powder, soluble in water and ethanol, insoluble in lipids, no smell bitter Character: This product has been highly purified into white powder crystal which can dissolve in water and ethanol but can't dissolve in fat. It is smelless and bitter with the purity of above 99.95%. The product should be kept in dark and dry place. Function: The acting principle of this product: NANC neuron and carbon monoxide enzyme of blood vessel endodermis cells catalyze the composition of carbon monoxide from L-Arginine. Carbon monoxide stimulates the composition of guanosine which can lead to the relaxation of smooth muscle of penis sponge and penis arteriole. The penis will have an erection when there is blood pouring into penis sponge. Thus, this product belongs to 5 types Vinpocetine. Effects: This product is re-composed which belongs to the derivatives. And its changeable forms LG-MS, HPLC have been tested by advanced facility and have passed international intellectual property protection policy. It doesn't belong to the protection scope but also doesn't in the forbidden scope of government. Harmful reaction: Headache, red face, nasal congestion, abnormal eyesight (barrier of distinguishing color in a short time). Scope: The one who takes medicine which contains nitrate and which can expand blood vessel can't take this product. And it is not applicable for the one who suffers from blood condensing barrier, active ulcer and retina inflammation.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top